Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Patients with acne and insulin resistance have different blood metabolites compared to those with only acne, which could help in diagnosis and treatment.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.

Higher levels of certain proteins may increase or decrease rosacea risk.

Sca-1+ cells in newborn mouse skin may become fat cells.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Retinoic acid production and signaling in hair follicles are regulated by location and timing, affecting hair growth and cycling.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Sirtuin 1 could be a potential drug target for treating hypertrophic scars.

Adipose-derived stem cells can be transformed into hair-forming cells using specific extracellular vesicles, offering potential for hair regeneration therapies.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Cholesterol transport in hair follicles decreases from growth to regression phase.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Alkaline Ceramidase 1 prevents early hair loss in mice by keeping hair follicle stem cells balanced.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Low estrogen due to poor nutrition can lead to non-alcoholic fatty liver disease.

CLK1 is needed for skin cells to become epidermal cells but not sebocytes.

Dsg1 is essential for maintaining a healthy skin barrier in mice.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.